Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy

por Xu, Wen Wen, Li, Bin, Lam, Alfred KY, Tsao, Sai Wah, Law, Simon YK, Chan, Kwok Wah, Yuan, Qiu Ju, Cheung, Annie LM
Publicado 2014

Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer

por Zhu, Yun, Lam, Alfred K.Y., Shum, Daisy K.Y., Cui, Di, Zhang, Jun, Yan, Dong Dong, Li, Bin, Xu, Wen Wen, Lee, Nikki P.Y., Chan, Kin Tak, Law, Simon, Tsao, Sai Wah, Cheung, Annie L.M.
Publicado 2021